Pfizer Limited

NSE PFIZER.NS

Pfizer Limited Net Income Margin for the year ending March 31, 2024: 25.14%

Pfizer Limited Net Income Margin is 25.14% for the year ending March 31, 2024, a -2.31% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Pfizer Limited Net Income Margin for the year ending March 31, 2023 was 25.73%, a 9.66% change year over year.
Pfizer Limited Net Income Margin for the year ending March 31, 2022 was 23.46%, a 5.55% change year over year.
Pfizer Limited Net Income Margin for the year ending March 31, 2021 was 22.23%, a -6.06% change year over year.
Pfizer Limited Net Income Margin for the year ending March 31, 2020 was 23.66%, a 14.80% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NSE: PFIZER.NS

Pfizer Limited

CEO	Ms. Meenakshi Nevatia
IPO Date	July 1, 2002
Location	India
Headquarters	The Capital
Employees	1,721
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

Key trends

Past 5 years